Eyenovia regains Nasdaq minimum bid price compliance after 10-day stretch over $1.00

HYPERION DEFI, INC.

Received Nasdaq confirmation on July 26, 2024 that compliance with Listing Rule 5550(a)(2) is regained.
Previously notified of non-compliance on July 2, 2024 with 180-day cure period through Dec 30, 2024.
Closing bid price at or above $1.00 for the ten consecutive business days from July 12 to July 25, 2024.
Company avoids delisting from Nasdaq Capital Market; no further bid-price deficiency action required.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.